Abstract: The inventive concept provides a substrate treating method. The substrate treating method includes supplying a liquid to a substrate; and heating the substrate after the supplying the liquid, and wherein the supplying the liquid includes: supplying a first liquid to the substrate; and supplying a second liquid which is different from the first liquid to a substrate to which the first liquid is supplied, and wherein the second liquid is supplied as a test to the substrate and a contact angle between the second liquid which is supplied and the substrate is measured to determine a degree of hydrophilization of the substrate, and a supply mechanism of the second liquid supplied to the substrate is determined based on the degree of hydrophilization of the substrate which is determined, before the supplying the second liquid is performed.

Abstract: The inventive concept provides a substrate treating method. The substrate treating method includes pre-treating a substrate by cleaning the substrate; etching the substrate by supplying an etchant and heating a substrate supplied with the etchant; and post-treating the substrate after the etching the substrate, and wherein the pre-treating the substrate, the etching the substrate, and the post-treating the substrate are each performed in different chambers, a substrate on which the pre-treating the substrate is completed is transferred in a dry state to a chamber at which the etching the substrate is performed, and a substrate on which the etching the substrate is completed is transferred in a wetted state with a liquid to a chamber at which the post-treating the substrate is performed.

Abstract: A system may have windows. The window may have first and second window layers and a layer of material such as guest-host liquid crystal material between the first and second window layers. Electrodes on the window layers may be used to apply electric fields to the guest-host liquid crystal material to adjust the light transmission properties of the window. To ensure that a desired gap between the first and second window layers is maintained, spacers may be formed between the first and second window layers. The spacers may include key-and-lock spacers that have interlocking portions located, respectively, on the first and second window layers. Spacers such as photoresist posts can be attached using adhesive. Hybrid arrangements may also be used in which key-and-lock spacer structures are attached using adhesive bonds.

Abstract: The present disclosure relates to a novel piperidine-2,6-dione derivative and a use thereof and, more specifically, to a piperidine-2,6-dione derivative compound having a structure of a thalidomide analog. A compound of chemical formula 1 according to the present disclosure specifically binds with CRBN protein, and is involved in functions thereof. Therefore, the compound of the present disclosure can be favorably used in the prevention or treatment of leprosy, chronic graft versus host disease, an inflammatory disease, or cancer, which are caused by actions of CRBN protein.

Abstract: An electronic device may be provided with a display. An optical component window may be formed in the inactive area of the display. The optical component window may transmit infrared light from an infrared light source. The infrared light source may include a diffuser to allow the light source to operate in a flood illumination mode and a structured light mode. The diffuser may include liquid crystal material between first and second substrates. A sealant may surround the liquid crystal layer, and one or more spacer walls may be located between the sealant and the liquid crystal layer. An additional spacer wall may be used outside of the sealant to prevent metal from creating an electrical short between electrodes in the diffuser. Conductive material in the sealant may be used to couple a top electrode to a metal pad on a bottom substrate.

Abstract: A liquid crystal display may have main column spacers and subspacer column spacers. The column spacers may have cross shapes formed from overlapping perpendicular rectangular column spacer portions respectively located on a color filter layer and a thin-film transistor layer. The column spacers may have a hybrid configuration in which some of the rectangular portions on the thin-film transistor layer extend vertically and some extend horizontally. Column spacers may be formed from planarization layer material, may be formed from locally thickened portions of a planarization layer, and may have circular shapes.

Abstract: The present disclosure relates to a novel piperidine-2,6-dione derivative and a use thereof and, more specifically, to a piperidine-2,6-dione derivative compound having a structure of a thalidomide analog. A compound of chemical formula 1 according to the present disclosure specifically binds with CRBN protein, and is involved in functions thereof. Therefore, the compound of the present disclosure can be favorably used in the prevention or treatment of leprosy, chronic graft versus host disease, an inflammatory disease, or cancer, which are caused by actions of CRBN protein.

Abstract: An electronic device may be provided with a display. An optical component window may be formed in the inactive area of the display. The optical component window may transmit infrared light from an infrared light source. The infrared light source may include a diffuser to allow the light source to operate in a flood illumination mode and a structured light mode. The diffuser may include liquid crystal material between first and second substrates. A sealant may surround the liquid crystal layer, and one or more spacer walls may be located between the sealant and the liquid crystal layer. An additional spacer wall may be used outside of the sealant to prevent metal from creating an electrical short between electrodes in the diffuser. Conductive material in the sealant may be used to couple a top electrode to a metal pad on a bottom substrate.

Abstract: A liquid crystal display may have main column spacers and subspacer column spacers. The column spacers may have cross shapes formed from overlapping perpendicular rectangular column spacer portions respectively located on a color filter layer and a thin-film transistor layer. The column spacers may have a hybrid configuration in which some of the rectangular portions on the thin-film transistor layer extend vertically and some extend horizontally. Column spacers may be formed from planarization layer material, may be formed from locally thickened portions of a planarization layer, and may have circular shapes.

Abstract: A display may have a layer of liquid crystal material between a color filter layer and a thin-film transistor layer. Column spacer structures may be formed between the color filter layer and the thin-film transistor layer to maintain a desired separation between the color filter and thin-film transistor layers. Column spacers may be deposited in column spacer regions of the color filter layer. The color filter layer may include rows of red, green, and blue color filter elements. Blue color filter material that forms blue color filter elements in the color filter layer may also be used to form a planar surface over red and green color filter elements in the column spacer regions. Using the blue color filter material to planarize the surface on which column spacers are formed ensures that the column spacers provide sufficient support for the display without requiring an additional planarization layer.

Abstract: A display may have a color filter layer and a thin-film transistor layer. A layer of liquid crystal material may be located between the color filter layer and the thin-film transistor layer. Column spacers may be formed on the color filter layer to maintain a desired gap between the color filter and thin-film transistor layers. Support pads may be used to support the column spacers. The column spacers and support pads may have comparable thicknesses. Different column spacers may be located at different portions of the support pads to allow the support pad size to be reduced while ensuring adequate support.

Abstract: The present invention relates to a novel triazolopyrazine derivative or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition containing the same as an active ingredient for preventing or treating hyper proliferative disorder. The present invention can be useful as a therapeutic agent for various hyper proliferative disorders associated with excessive cell proliferation and growth caused by abnormal kinase activity, such as cancer, psoriasis, rheumatoid arthritis, and diabetic retinopathy, by efficiently inhibiting c-Met tyrosine kinase activity.

Abstract: A display may have a color filter layer and a thin-film transistor layer. A layer of liquid crystal material may be located between the color filter layer and the thin-film transistor layer. Column spacers may be formed on the color filter layer to maintain a desired gap between the color filter and thin-film transistor layers. Support pads may be used to support the column spacers. The column spacers and support pads may have comparable thicknesses. Different column spacers may be located at different portions of the support pads to allow the support pad size to be reduced while ensuring adequate support.

Abstract: Disclosed herein are a new N2,N4-bis(4-(piperazin-1-yl)phenyl)pyrimidin-2,4-diamine derivative or a pharmaceutically acceptable salt thereof and a pharmaceutical composition for the prevention or treatment of cancers containing the same as an active ingredient. The compound of the present invention has excellent inhibitory effects against the activities of anaplastic lymphoma kinase (ALK) and activated cdc42-associated kinase (ACK1) and thus can improve the therapeutic effects on the treatment of cancer cells having anaplastic lymphoma kinase fusion proteins such as EML4-ALK and NPM-ALK, and also effectively prevent the recurrence of cancers thus being useful as a pharmaceutical composition for the prevention and treatment of cancers.

Abstract: The present invention relates to a novel triazolopyrazine derivative or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition containing the same as an active ingredient for preventing or treating hyper proliferative disorder. The present invention can be useful as a therapeutic agent for various hyper proliferative disorders associated with excessive cell proliferation and growth caused by abnormal kinase activity, such as cancer, psoriasis, rheumatoid arthritis, and diabetic retinopathy, by efficiently inhibiting c-Met tyrosine kinase activity.

Abstract: A display may have a layer of liquid crystal material between a color filter layer and a thin-film transistor layer. Column spacer structures may be formed between the color filter layer and the thin-film transistor layer to maintain a desired separation between the color filter and thin-film transistor layers. Column spacers may be deposited in column spacer regions of the color filter layer. The color filter layer may include rows of red, green, and blue color filter elements. Blue color filter material that forms blue color filter elements in the color filter layer may also be used to form a planar surface over red and green color filter elements in the column spacer regions. Using the blue color filter material to planarize the surface on which column spacers are formed ensures that the column spacers provide sufficient support for the display without requiring an additional planarization layer.

Abstract: Disclosed herein are a new N2,N4-bis(4-(piperazin-1-yl)phenyl)pyrimidin-2,4-diamine derivative or a pharmaceutically acceptable salt thereof and a pharmaceutical composition for the prevention or treatment of cancers containing the same as an active ingredient. The compound of the present invention has excellent inhibitory effects against the activities of anaplastic lymphoma kinase (ALK) and activated cdc42-associated kinase (ACK1) and thus can improve the therapeutic effects on the treatment of cancer cells having anaplastic lymphoma kinase fusion proteins such as EML4-ALK and NPM-ALK, and also effectively prevent the recurrence of cancers thus being useful as a pharmaceutical composition for the prevention and treatment of cancers.

Abstract: The present invention relates to benzopyran derivatives substituted with secondary amines including imidazole, their preparation, and pharmaceutical compositions containing them. The present invention is pharmacologically useful for the treatment of cancer, rheumatoid arthritis, and diabetic retinopathies through anti-angiogenic properties, and also pharmacologically useful in the protection of heart and neuronal cells against ischemia-reperfusion injury or preserving organs.

Abstract: A VVA-mode LCD having improved transmittance and response speed includes upper and lower substrates positioned to face each other with a predetermined distance between them; a liquid crystal layer having negative anisotropy of dielectric constant interposed between the upper and lower substrates; a color resin layer formed on the inner surface of the upper substrate and having a predetermined number of valleys regularly formed inside each unit pixel; a counter electrode formed on the color resin layer including the valleys; a pixel electrode formed on the inner surface of the lower substrate and having slits arranged about the valleys of the upper substrate in a “+” shape inside and around the valleys; and alignment layers interposed between the pixel electrode and the liquid crystal layer and between the counter electrode and the liquid crystal layer, respectively.

Abstract: The present invention relates to benzopyran derivatives substituted with secondary amines including imidazole, their preparation, and pharmaceutical compositions containing them. The present invention is pharmacologically useful for the treatment of cancer, rheumatoid arthritis, and diabetic retinopathies through anti-angiogenic properties, and also pharmacologically useful in the protection of heart and neuronal cells against ischemia-reperfusion injury or preserving organs.